Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Journal of Gastroenterology and Hepatology|February 8, 2021
Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check-up in JapanKoji Otani, Toshio Watanabe, Kanae Takahashi, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2021
Pyogenic Spondylitis Caused by Staphylococcus schleiferi in a Patient with Crohn's DiseaseKoji Fujimoto, Shuhei Hosomi, Rieko Nakata, et al.
BMC Gastroenterology|May 3, 2023
Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in JapanKoji Otani, Toshio Watanabe, Kanae Takahashi, et al.
Plos One|April 22, 2021
The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patientsMaizumi Furuse, Shuhei Hosomi, Yu Nishida, et al.
Digestion|October 12, 2020
Safety of Endoscopic Mucosal Resection Using a Bipolar Snare for Superficial Nonampullary Duodenal Epithelial Tumors and the Predictive Factors of Piecemeal ResectionMasafumi Yamamura, Yasuaki Nagami, Taishi Sakai, et al.
Clinical and Translational Gastroenterology|September 21, 2020
Repeated Endoscopic Submucosal Dissection for Esophageal Neoplasia Located Close to a Previous Endoscopic Submucosal Dissection ScarYasuaki Nagami, Masaki Ominami, Taishi Sakai, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 7, 2022
Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitisAtsushi Kanamori, Fumio Tanaka, Shingo Takashima, et al.
Digestive Diseases and Sciences|December 24, 2014
Efficacy of concomitant elemental diet therapy in scheduled infliximab therapy in patients with Crohn's disease to prevent loss of responseNoriko Kamata, Nobuhide Oshitani, Kenji Watanabe, et al.
Plos One|May 4, 2021
Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damageTakuya Kuzumoto, Tetsuya Tanigawa, Akira Higashimori, et al.
Scandinavian Journal of Gastroenterology|November 25, 2017
Serum interleukin-6 level is associated with response to infliximab in ulcerative colitisYu Nishida, Shuhei Hosomi, Kenji Watanabe, et al.
Pageof 14